Preclinical Animal Models: Selection & Rationale

About
Privacy
Disclaimer

Graph Chatbot

Related lectures (32)

Page 2 of 4

Drug Development and Regulations: Europe

Explores drug development and regulations in Europe, focusing on clinical trials, regulatory frameworks, and marketing authorization procedures.

Pharmacokinetic & Pharmacodynamic Studies

Discusses the importance of assessing PK/PD relationships in drug development and the use of multiple PD biomarkers.

Kidney-on-a-Chip Technologies

Covers the state-of-the-art kidney-on-chip technologies aiming to facilitate pharmaceutical research and eliminate animal testing.

Frontiers in Chemical Biology

Explores the druggable proteome, PROTACS strategy, ubiquitin attachment, and drug development paradigms.

Identifying Drug Targets: Safety and Efficacy

Delves into identifying drug targets, ensuring efficacy, and maintaining safety in medical chemistry, covering genetic tests, chirality, stereochemistry, drug resistance, and drug-likeness rules.

Causality and Clinical Studies

Explores causality, clinical studies, new drug evaluation, confounding factors, and data analysis methods.

Drug Discovery: Computational Approaches

Explores the EXSCALATE4COV project, focusing on computational drug discovery for COVID-19 treatments and the collaboration between academia and industry.

Engineering brain activity patterns for therapeutics

Discusses correcting aberrant brain-wide activity patterns using distinct network motifs and neuromodulators.

Cyclic Peptides and Macrocycles

Explores cyclic peptides and macrocycles, their applications in drug development, and the role of bicyclic peptides in targeting specific proteins.

Enzyme Drug Targets

Explores enzyme drug targets, tyrosine kinase inhibitors, vascular tone control, and viral life cycle interventions.